Literature DB >> 11552981

The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.

U Vinatzer1, J Taplick, C Seiser, C Fonatsch, R Wieser.   

Abstract

EVI-1 and its variant form, MDS1/EVI1, have been reported to act in an antagonistic manner and be differentially regulated in samples from patients with acute myeloid leukaemia and rearrangements of the long arm of chromosome 3. Here, we show that both EVI-1 and MDS1/EVI1 can repress transcription from a reporter construct containing EVI-1 binding sites and interact with histone deacetylase in mammalian cells. This interaction can be recapitulated in vitro and is mediated by a previously characterized transcription repression domain, whose activity is alleviated by the histone deacetylase inhibitor trichostatin A.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552981     DOI: 10.1046/j.1365-2141.2001.02987.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  Evi-1 as a critical regulator of leukemic cells.

Authors:  Susumu Goyama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-06-08       Impact factor: 2.490

2.  Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Authors:  Boris Calmels; Cole Ferguson; Mikko O Laukkanen; Rima Adler; Marion Faulhaber; Hyeoung-Joon Kim; Stephanie Sellers; Peiman Hematti; Manfred Schmidt; Christof von Kalle; Keiko Akagi; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

3.  EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.

Authors:  Eric M J Bindels; Marije Havermans; Sanne Lugthart; Claudia Erpelinck; Elizabeth Wocjtowicz; Andrei V Krivtsov; Elwin Rombouts; Scott A Armstrong; Erdogan Taskesen; Jurgen R Haanstra; H Berna Beverloo; Hartmut Döhner; Wendy A Hudson; John H Kersey; Ruud Delwel; Ashish R Kumar
Journal:  Blood       Date:  2012-05-02       Impact factor: 22.113

4.  Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.

Authors:  Sanne Lugthart; Maria E Figueroa; Eric Bindels; Lucy Skrabanek; Peter J M Valk; Yushan Li; Stefan Meyer; Claudia Erpelinck-Verschueren; John Greally; Bob Löwenberg; Ari Melnick; Ruud Delwel
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

5.  Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.

Authors:  Sonja C Bingemann; Torsten A Konrad; Rotraud Wieser
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

6.  The conserved and divergent roles of Prdm3 and Prdm16 in zebrafish and mouse craniofacial development.

Authors:  Lomeli Carpio Shull; Rwik Sen; Johannes Menzel; Susumu Goyama; Mineo Kurokawa; Kristin Bruk Artinger
Journal:  Dev Biol       Date:  2020-02-08       Impact factor: 3.582

Review 7.  Evi1 forms a bridge between the epigenetic machinery and signaling pathways.

Authors:  Akihide Yoshimi; Mineo Kurokawa
Journal:  Oncotarget       Date:  2011-07

Review 8.  Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights.

Authors:  Saeid Shahrabi; Abbas Khosravi; Mohammad Shahjahani; Fakher Rahim; Najmaldin Saki
Journal:  Oncol Rev       Date:  2016-12-14

9.  Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.

Authors:  Torsten A Konrad; Anna Karger; Hubert Hackl; Ilse Schwarzinger; Irene Herbacek; Rotraud Wieser
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.